Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 209 entries
Sorted by: Best Match Show Resources per page
An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids.

Journal of pharmaceutical and biomedical analysis

Shepley K, Rocci ML, Patrick H, Mojaverian P.
PMID: 16867414
J Pharm Biomed Anal. 1988;6(3):241-51. doi: 10.1016/0731-7085(88)80050-5.

An easy, analytically sound fluoroenzymatic assay for angiotensin converting enzyme (ACE) inhibitors is described. Drug samples and standards are extracted with methanol and evaporated to dryness. Drug residues are then incubated with the substrate N-benzyloxycarbonyl-phenyllanyl-l-histidyl-leucine and human plasma ACE...

Cite
Shepley K, Rocci ML, Patrick H, et al. An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids. J Pharm Biomed Anal. 1988;6(3):241-51doi: 10.1016/0731-7085(88)80050-5.
Shepley, K., Rocci, M. L., Patrick, H., & Mojaverian, P. (1988). An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids. Journal of pharmaceutical and biomedical analysis, 6(3), 241-51. https://doi.org/10.1016/0731-7085(88)80050-5
Shepley, K, et al. "An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids." Journal of pharmaceutical and biomedical analysis vol. 6,3 (1988): 241-51. doi: https://doi.org/10.1016/0731-7085(88)80050-5
Shepley K, Rocci ML, Patrick H, Mojaverian P. An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids. J Pharm Biomed Anal. 1988;6(3):241-51. doi: 10.1016/0731-7085(88)80050-5. PMID: 16867414.
Copy Download .nbib Format: NLM
Amlodipine or lisinopril was not better than chlorthalidone in reducing renal outcomes in hypertension and impaired renal function.

ACP journal club

Tonelli M, McFarlane P.
PMID: 16134919
ACP J Club. 2005 Sep-Oct;143(2):45.

No abstract available.

Cite
Tonelli M, McFarlane P. Amlodipine or lisinopril was not better than chlorthalidone in reducing renal outcomes in hypertension and impaired renal function. ACP J Club. 2005;143(2):45
Tonelli, M., & McFarlane, P. (2005). Amlodipine or lisinopril was not better than chlorthalidone in reducing renal outcomes in hypertension and impaired renal function. ACP journal club, 143(2), 45.
Tonelli, Marcello, and McFarlane, Phil. "Amlodipine or lisinopril was not better than chlorthalidone in reducing renal outcomes in hypertension and impaired renal function." ACP journal club vol. 143,2 (2005): 45.
Tonelli M, McFarlane P. Amlodipine or lisinopril was not better than chlorthalidone in reducing renal outcomes in hypertension and impaired renal function. ACP J Club. 2005 Sep-Oct;143(2):45. PMID: 16134919.
Copy Download .nbib Format: NLM
Lisinopril cough.

Texas Heart Institute journal

Nash DT.
PMID: 15227340
Tex Heart Inst J. 1987 Mar;14(1):106.

No abstract available.

Cite
Nash DT. Lisinopril cough. Tex Heart Inst J. 1987;14(1):106
Nash, D. T. (1987). Lisinopril cough. Texas Heart Institute journal, 14(1), 106.
Nash, D T. "Lisinopril cough." Texas Heart Institute journal vol. 14,1 (1987): 106.
Nash DT. Lisinopril cough. Tex Heart Inst J. 1987 Mar;14(1):106. PMID: 15227340; PMCID: PMC324703.
Copy Download .nbib Format: NLM
Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats.

Indian journal of pharmacology

Morsy MA.
PMID: 22144768
Indian J Pharmacol. 2011 Nov;43(6):652-5. doi: 10.4103/0253-7613.89820.

OBJECTIVE: Ischemia/reperfusion (I/R) injury plays a key role in the pathogenesis of hepatic failure in several clinical settings such as liver resection or transplantation. Lisinopril, a widely prescribed drug for various cardiovascular conditions, has been reported to have diverse...

Cite
Morsy MA. Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian J Pharmacol. 2011;43(6):652-5doi: 10.4103/0253-7613.89820.
Morsy, M. A. (2011). Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian journal of pharmacology, 43(6), 652-5. https://doi.org/10.4103/0253-7613.89820
Morsy, M A. "Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats." Indian journal of pharmacology vol. 43,6 (2011): 652-5. doi: https://doi.org/10.4103/0253-7613.89820
Morsy MA. Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian J Pharmacol. 2011 Nov;43(6):652-5. doi: 10.4103/0253-7613.89820. PMID: 22144768; PMCID: PMC3229779.
Copy Download .nbib Format: NLM
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.

Patient preference and adherence

Mancia G, Schumacher H.
PMID: 22272064
Patient Prefer Adherence. 2012;6:1-9. doi: 10.2147/PPA.S27939. Epub 2011 Dec 23.

Telmisartan is indicated for the prevention of cardiovascular events in high-risk patients, based on comparable efficacy to the angiotensin-converting enzyme (ACE) inhibitor, ramipril, in the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET(®)) trial. However,...

Cite
Mancia G, Schumacher H. Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient Prefer Adherence. 2011;6:1-9doi: 10.2147/PPA.S27939.
Mancia, G., & Schumacher, H. (2012). Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient preference and adherence, 61-9. https://doi.org/10.2147/PPA.S27939
Mancia, Giuseppe, and Schumacher, Helmut. "Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials." Patient preference and adherence vol. 6 (2012): 1-9. doi: https://doi.org/10.2147/PPA.S27939
Mancia G, Schumacher H. Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials. Patient Prefer Adherence. 2012;6:1-9. doi: 10.2147/PPA.S27939. Epub 2011 Dec 23. PMID: 22272064; PMCID: PMC3262485.
Copy Download .nbib Format: NLM
Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide.

Endocrinology, diabetes & metabolism case reports

Elshafie O, Al Badaai Y, Alwahaibi K, Qureshi A, Hussein S, Al Azzri F, Almamari A, Woodhouse N.
PMID: 25136449
Endocrinol Diabetes Metab Case Rep. 2014;2014:140051. doi: 10.1530/EDM-14-0051. Epub 2014 Jul 01.

UNLABELLED: A 48-year-old hypertensive and diabetic patient presented with a 10-year history of progressive right facial pain, tinnitus, hearing loss, sweating, and palpitations. Investigations revealed a 5.6 cm vascular tumor at the carotid bifurcation. Her blood pressure (BP) was...

Cite
Elshafie O, Al Badaai Y, Alwahaibi K, et al. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinol Diabetes Metab Case Rep. 2014;2014:140051doi: 10.1530/EDM-14-0051.
Elshafie, O., Al Badaai, Y., Alwahaibi, K., Qureshi, A., Hussein, S., Al Azzri, F., Almamari, A., & Woodhouse, N. (2014). Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinology, diabetes & metabolism case reports, 2014140051. https://doi.org/10.1530/EDM-14-0051
Elshafie, Omayma, et al. "Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide." Endocrinology, diabetes & metabolism case reports vol. 2014 (2014): 140051. doi: https://doi.org/10.1530/EDM-14-0051
Elshafie O, Al Badaai Y, Alwahaibi K, Qureshi A, Hussein S, Al Azzri F, Almamari A, Woodhouse N. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinol Diabetes Metab Case Rep. 2014;2014:140051. doi: 10.1530/EDM-14-0051. Epub 2014 Jul 01. PMID: 25136449; PMCID: PMC4120363.
Copy Download .nbib Format: NLM
Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate.

Blood pressure monitoring

Baguet JP, De Gaudemaris R, Mallion JM, Noirclerc M, Siché JP.
PMID: 10212353
Blood Press Monit. 1998 Jun;3(3):189-194.

BACKGROUND: Ambulatory blood pressure measurements allow better evaluation of the effects of antihypertensive drugs on the diurnal profile of blood pressure. Various strategies, such as determining peak: trough ratio and smoothness indexd, with and without smoothing of raw data...

Cite
Baguet JP, De Gaudemaris R, Mallion JM, et al. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood Press Monit. 1998;3(3):189-194
Baguet, J. P., De Gaudemaris R, Mallion, J. M., Noirclerc, M., & Siché, J. P. (1998). Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood pressure monitoring, 3(3), 189-194.
Baguet, et al. "Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate." Blood pressure monitoring vol. 3,3 (1998): 189-194.
Baguet JP, De Gaudemaris R, Mallion JM, Noirclerc M, Siché JP. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate. Blood Press Monit. 1998 Jun;3(3):189-194. PMID: 10212353.
Copy Download .nbib Format: NLM
Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient.

Cureus

Elshimy G, Techathaveewat P, Alsayed M, Jyothinagaram S, Correa R.
PMID: 31489273
Cureus. 2019 Aug 21;11(8):e5449. doi: 10.7759/cureus.5449.

Angiotensin-converting enzyme (ACE) inhibitors are among the most common medications used to treat patients with concomitant diabetes and hypertension. They are considered the first line of treatment for hypertension in this population. Several case studies have reported that ACE...

Cite
Elshimy G, Techathaveewat P, Alsayed M, et al. Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient. Cureus. 2019;11(8):e5449doi: 10.7759/cureus.5449.
Elshimy, G., Techathaveewat, P., Alsayed, M., Jyothinagaram, S., & Correa, R. (2019). Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient. Cureus, 11(8), e5449. https://doi.org/10.7759/cureus.5449
Elshimy, Ghada, et al. "Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient." Cureus vol. 11,8 (2019): e5449. doi: https://doi.org/10.7759/cureus.5449
Elshimy G, Techathaveewat P, Alsayed M, Jyothinagaram S, Correa R. Simple Reason for Hypoglycemia: ACE Inhibitor-induced Severe Recurrent Hypoglycemia in a Nondiabetic Patient. Cureus. 2019 Aug 21;11(8):e5449. doi: 10.7759/cureus.5449. PMID: 31489273; PMCID: PMC6713252.
Copy Download .nbib Format: NLM
Overview of management of acute renal failure and its evaluation; a case analysis.

Journal of nephropharmacology

Nazar CM, Bashir F, Izhar S, Anderson J.
PMID: 28197469
J Nephropharmacol. 2015 Jan 01;4(1):17-22. eCollection 2015.

The annual incidence is about 150 per million in the UK, but this figure is six times greater in the >80 years old group. Prerenal azotemia is considered as the most serious reason in community or hospital acquired acute...

Cite
Nazar CM, Bashir F, Izhar S, et al. Overview of management of acute renal failure and its evaluation; a case analysis. J Nephropharmacol. 2015;4(1):17-22
Nazar, C. M., Bashir, F., Izhar, S., & Anderson, J. (2015). Overview of management of acute renal failure and its evaluation; a case analysis. Journal of nephropharmacology, 4(1), 17-22.
Nazar, Chaudhary Muhammad Junaid, et al. "Overview of management of acute renal failure and its evaluation; a case analysis." Journal of nephropharmacology vol. 4,1 (2015): 17-22.
Nazar CM, Bashir F, Izhar S, Anderson J. Overview of management of acute renal failure and its evaluation; a case analysis. J Nephropharmacol. 2015 Jan 01;4(1):17-22. eCollection 2015. PMID: 28197469; PMCID: PMC5297473.
Copy Download .nbib Format: NLM
Recurrent Hypertriglyceridemic Pancreatitis (HTGP); and the Use of Insulin Drip as Treatment.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society

Tran T, Lee N.
PMID: 28414683
J La State Med Soc. 2017 Mar-Apr;169(2):55-56. Epub 2017 Apr 15.

INTRODUCTION: Chronic pancreatitis by definition is a recurrent episode of acute pancreatitis and is commonly associated with alcoholism in the US. Another cause of chronic pancreatitis is hypertriglyceridemia (HTGP);, occurring in 1-5 percent of cases. The incidence of HTGP...

Cite
Tran T, Lee N. Recurrent Hypertriglyceridemic Pancreatitis (HTGP); and the Use of Insulin Drip as Treatment. J La State Med Soc. 2017;169(2):55-56
Tran, T., & Lee, N. (2017). Recurrent Hypertriglyceridemic Pancreatitis (HTGP); and the Use of Insulin Drip as Treatment. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 169(2), 55-56.
Tran, T, and Lee, N. "Recurrent Hypertriglyceridemic Pancreatitis (HTGP); and the Use of Insulin Drip as Treatment." The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society vol. 169,2 (2017): 55-56.
Tran T, Lee N. Recurrent Hypertriglyceridemic Pancreatitis (HTGP); and the Use of Insulin Drip as Treatment. J La State Med Soc. 2017 Mar-Apr;169(2):55-56. Epub 2017 Apr 15. PMID: 28414683.
Copy Download .nbib Format: NLM
Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats.

Advances in pharmacological sciences

Deb D, Bairy KL, Nayak V, Rao M.
PMID: 26300914
Adv Pharmacol Sci. 2015;2015:521718. doi: 10.1155/2015/521718. Epub 2015 Aug 02.

Lisinopril and fosinopril were compared on scopolamine-induced learning and memory deficits in rats. A total of eighty-four male Wistar rats were divided into seven groups. Group I received 2% gum acacia orally for 4 weeks, group II received normal...

Cite
Deb D, Bairy KL, Nayak V, et al. Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. Adv Pharmacol Sci. 2015;2015:521718doi: 10.1155/2015/521718.
Deb, D., Bairy, K. L., Nayak, V., & Rao, M. (2015). Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. Advances in pharmacological sciences, 2015521718. https://doi.org/10.1155/2015/521718
Deb, Debasree, et al. "Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats." Advances in pharmacological sciences vol. 2015 (2015): 521718. doi: https://doi.org/10.1155/2015/521718
Deb D, Bairy KL, Nayak V, Rao M. Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. Adv Pharmacol Sci. 2015;2015:521718. doi: 10.1155/2015/521718. Epub 2015 Aug 02. PMID: 26300914; PMCID: PMC4537708.
Copy Download .nbib Format: NLM
Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report.

Oman medical journal

Al-Hoqani ZK, Al-Kiyumi MH, Al-Tamemi SH, Al-Mahrezi AM.
PMID: 32042467
Oman Med J. 2020 Feb 10;35(1):e92. doi: 10.5001/omj.2020.10. eCollection 2020 Jan.

Tongue angioedema is a well-recognized side effect of angiotensin-converting enzyme inhibitor particularly during the first few months of initiation. Unilateral tongue involvement is rarely encountered. We report the case of a 78-year-old woman who presented with unilateral right side...

Cite
Al-Hoqani ZK, Al-Kiyumi MH, Al-Tamemi SH, et al. Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report. Oman Med J. 2020;35(1):e92doi: 10.5001/omj.2020.10.
Al-Hoqani, Z. K., Al-Kiyumi, M. H., Al-Tamemi, S. H., & Al-Mahrezi, A. M. (2020). Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report. Oman medical journal, 35(1), e92. https://doi.org/10.5001/omj.2020.10
Al-Hoqani, Zamzam Khalaf, et al. "Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report." Oman medical journal vol. 35,1 (2020): e92. doi: https://doi.org/10.5001/omj.2020.10
Al-Hoqani ZK, Al-Kiyumi MH, Al-Tamemi SH, Al-Mahrezi AM. Unilateral Tongue Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: A Case Report. Oman Med J. 2020 Feb 10;35(1):e92. doi: 10.5001/omj.2020.10. eCollection 2020 Jan. PMID: 32042467; PMCID: PMC7008133.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 209 entries